ABM-3249

N/A

Report date: 2025/01/26 18:24:11
NME

Base Information

Drug NameABM-3249
Drug Alias NameCDK8 inhibitor (ABM Therapeutics)ABM-3249
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 8 inhibitors
TargetsCyclin-dependent kinase 8
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesABM Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesABM Therapeutics
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A